Logo
x

Search

Subscribe Now

enGene

enGene to go Public via Forbion European Acquisition Corp. SPAC Merger for ~$135M

enGene to go Public via Forbion European Acquisition Corp. SPAC Merger for ~$135M

  • May 19, 2023
enGene Reports Preliminary Results of EG-70 in P-I/II (LEGEND) Trial for the Treatment of Non-Muscle Invasive Bladder Cancer

enGene Reports Preliminary Results of EG-70 in P-I/II (LEGEND) Trial for the Treatment of Non-Muscle Invasive Bladder Cancer

  • February 10, 2022
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.